阻塞性睡眠呼吸暂停的药物治疗:针对特定的病理生理特征.
Elisa Perger1, Simona Bertoli1,2,3, Carolina Lombardi1,4
1Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Expert review of respiratory medicine
|August 30, 2023
概括
针对阻塞性睡眠呼吸暂停 (OSA) 病理生理学的新药学治疗方法提供了希望. 了解个体患者的特征将使精准医学方法能够更好地管理睡眠障碍呼吸.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 的病理生理学是复杂的和多因素的.
- 确定的特征包括喉缩性,上呼吸道肌肉反应性,兴奋值和通风驱动调节.
- 像CPAP这样的当前治疗方法有局限性,需要新的治疗策略.
研究的目的:
- 探索针对特定病理生理内型的OSA新药治疗方法.
- 审查影响OSA机制的现有和新兴药物.
- 根据它们对OSA关键特征的作用来总结有前途的药物治疗方法.
主要方法:
- 对药理学药物的文献综述及其对OSA病理生理学的影响.
- 对与上呼吸道折叠性,肌肉反应能力,兴奋值和循环增长相关的药物机制的分析.
- 有针对性的OSA治疗方法的证据综合.
主要成果:
- 几种药理学药物通过影响特定的OSA内型表现出潜力.
- 药物可以调节喉折叠性,肌肉活动,兴奋值和呼吸控制.
- 疗法组合可能会提供超越传统方法的多种治疗选择.
结论:
- 了解个体OSA病理生理学对于有效的干预至关重要.
- 药理学的进步为OSA治疗中的精准医学铺平了道路.
- 未来的睡眠专家可能根据患者特定的疾病机制量身定制治疗方法.
相关概念视频
Sleep Apnea
184
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
184
Management of Insomnia
278
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
278
Sedatives and Hypnotics Drugs: Miscellaneous Agents
200
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
200
Sedatives and Hypnotics: Overview
440
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
440
Narcolepsy
137
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
137
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


